. Raloxifene leads to higher bound water (A) and lower free water (B) in the cortical 158 bone following 6 months of treatment. In vivo assessment of hydration was done using UTE-159 MRI. n= 6 animals per treatment group. Data presented as means ± standard error of the 160 mean. * p = 0.05 between groups using a one-tailed t-test as described in the statistics section.
Raloxifene positively affects mechanical properties of the bone matrix in part through 24 modification of skeletal bound water. The goal of this study was to determine if raloxifene-25 induced alterations in skeletal hydration could be measured in vivo using ultra-short echotime 26 magnetic resonance imaging (UTE-MRI). Twelve skeletally mature female beagle dogs 27 (n=6/group) were treated for 6 months with oral doses of saline vehicle (VEH, 1 ml/kg/day) or 28 raloxifene (RAL, 0.5 mg/kg/day). Following six months of treatment, all animals underwent in 29 vivo UTE-MRI of the proximal tibial cortical bone. UTE-MRI signal intensity versus echotime 30 curves were analyzed by fitting a double exponential to determine the short and long relaxation 31 times of water with the bone (dependent estimations of bound and free water, respectively). 32
Raloxifene-treated animals had significantly higher bound water (+14%; p = 0.05) and lower free 33 water (-20%) compared to vehicle-treated animals. These data provide the first evidence that 34 drug-induced changes in skeletal hydration can be non-invasively assessed using UTE-MRI. . Preclinical studies in a dog model have documented a positive effect of raloxifene on 39 material-level biomechanical properties (the properties of the tissue independent of bone mass) 40 using both estimated material properties from whole bone tests (vertebra, femoral neck, rib) and 41 direct assessment on beams from femoral bone (4, 5) . Recent work has identified changes in 42 skeletal hydration, specifically increases in matrix-bound water, as a key factor in this positive 43 material-level adaption of bone. Treatment with raloxifene for one year in beagle dogs led to 44 significantly more total skeletal water, assessed gravimetrically, and this was positively 45 associated with the bone's mechanical properties (6) . Ultra-short echotime MRI (UTE-MRI) can 46 differentiate hydration status of bone under various conditions (7) (8) (9) . More detailed assessment 47 of raloxifene's effects on bone hydration using UTE-MRI revealed that ex vivo soaking of cortical 48 bone (both dog and human) in raloxifene resulted in more matrix bound water compared to 49 control of bone (6) . As UTE-MRI may have potential for clinical application (10) , the goal of this 50 study was to test the hypothesis that UTE-MRI can be used in vivo as a diagnostic indicator to 51 detect changes in bone hydration caused by pharmacological interventions. 52
METHODS 53

Experimental design 54
Twelve skeletally mature female beagles (1-2 years old) were treated with one of two conditions 55 for 6 months (n=6 per group): daily oral saline vehicle (1 mL/kg) or daily oral raloxifene (0.5 56 mg/kg). Raloxifene was dissolved in 10% hydroxypropyl-β-cyclodextrin and administered at a 57 . After six months of treatment, all 60 animals underwent in vivo UTE-MRI. All procedures were approved by the Indiana University 61
School of Medicine Animal Care and Use Committee, and were conducted in accordance with 62 NIH and USDA guidelines on animal care and use prior to the start of the study. 63
Ultra-short Echotime MRI (UTE-MRI) 64
Prior to imaging, anesthesia was induced with a combination of ketamine (8mg/kg) and 65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 where the distal and proximal limits were prescribed at a fixed distance from the center of the 86 FOV. Segmented regions were then extracted for all TE1 and TE2 images volumes, thereby 87 permitting secondary analysis of the UTE signal. To correct for receiver gain offset differences 88 between successive images, the following scaling was applied: 89
Where, F(TE1, j), M(TE2, j), C(TE1, j), and C c (TE1, j) are the correction factors at the "jth" TE1, 90 average marrow intensity at the "jth" TE2, average cortical bone intensity at the "jth" TE1, and 91 corrected image intensity at the "jth" TE1. To improve model fits in low signal to noise data, 92 images were corrected according to the methods of Miller and Joseph (14) and individually 93 modeled using a double exponential decay 
Where, TE1, a, ܶ2 * , b, ܶ2 ி * , and ܵሺܶ‫,1ܧ‬ ݇ሻ are the variable TE as described above, intercept for 95 the bound fraction, ܶ2 * for the bound fraction, intercept for the free fraction, ܶ2 * for the free 96 fraction, and the noise-free signal decay for the "kth" subject. In order to compute the percent 97 bound (%B(k)) and free (%F(k)) water in the system for the "kth" subject, Eqns 4 and 5 were 98
employed. 99
Statistics 100 UTE-MRI data were evaluated using unpaired Students T-tests. Based on our previous work 101 showed improvement in hydration of raloxifene-treated bone, a one-tailed t-test was used. For 102 all statistical tests, a priori α-levels were set at 0.05. 103
RESULTS 104
Images acquired over the TE1 range from 0.05 to 1.1 ms resulted in high signal to noise ratios 105 which ranged from 3.89±0.207 to 2.41±0.093, respectively ( Figure 1A-B) . respectively. UTE-MRI assessment of bound and free water was assessed in the cortical bone 111 of the proximal tibia ( Figure 2A&B) . Raloxifene treatment for 6 months led to significantly more 112 bound water (+14%) and significantly less free water (-20%) when compared to vehicle-treated 113 animals (p=0.05, n=6/grp). 114
DISCUSSION 115
Given the emerging interest in UTE-MRI as a tool to assess bone hydration (7) (8) (9) (10) and the recent 116 evidence from our lab that raloxifene positively affects bone hydration to control animals and that this is detectable using in vivo UTE-MRI scanning. 120
Our analysis showed raloxifene treatment resulted in higher bound water -consistent 121 with our previous work (6) . In addition, the rate constants from the UTE-MRI were consistent 122 with previous data in ex vivo bone samples (7) . The mechanisms underlying raloxifene's positive 123 effects on bound water remain to be determined. Our previous work points to the increased 124 bound water at the collagen/mineral interface, effectively increasing the ability of the mineral 125 and collagen to dissipate energy and toughen the matrix. This effect occurs independent of 126 bone turnover and is cell-independent (6) ; although there are clearly cell-dependent effects of 127 raloxifene (15) and these could be contributing to changes in hydration. 128
The current study using UTE-MRI was only able to assess relative amounts of water 129 (bound/free). Thus, it's possible that changes in bound water were influenced by changes in 130 free water. Although we were not able to directly measure porosity, a major determinant of free 131 water, in these animals we have previously documented the intracortical turnover rate of tibia in 132 this age dog is 1-2% per year (16, 17) . Suppression of intracortical remodeling, as would be 133 expected with raloxifene, would therefore produce minimal changes in porosity, especially over 134 6 months (the remodeling cycle in a dog is ~ 3 months long (18) ). Based on this, it is unlikely free 135 water changes would account for the entire difference between groups quantified in the current 136 work. Future work should employ standards that allow absolute volumes of free/bound water 137 using UTE-MRI and/or should confirm these in vivo findings with ex vivo analyses by NMR. 138
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